Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/32103
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Srinivasan, Ashish | - |
dc.contributor.author | De Cruz, Peter P | - |
dc.contributor.author | Sam, Melissa | - |
dc.contributor.author | Toong, Catherine | - |
dc.contributor.author | van Langenberg, Daniel R | - |
dc.date | 2023 | - |
dc.date.accessioned | 2023-02-07T05:52:08Z | - |
dc.date.available | 2023-02-07T05:52:08Z | - |
dc.date.issued | 2023-05 | - |
dc.identifier.citation | Journal of Gastroenterology and Hepatology 2023-05; 38(5) | en_US |
dc.identifier.issn | 1440-1746 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/32103 | - |
dc.description.abstract | The optimal infliximab dose intensification strategy to address secondary loss of response (LOR) remains unclear. This study aimed to compare clinical and pharmacokinetic outcomes following (i) upfront infliximab re-induction with (ii) ongoing 6-weekly dose interval shortening (DIS), after the same number of doses. | en_US |
dc.language.iso | eng | - |
dc.subject | Anti-tumor necrosis factor | en_US |
dc.subject | Crohn's disease | en_US |
dc.subject | Dose intensification | en_US |
dc.subject | Secondary loss of response | en_US |
dc.subject | Tertiary nonresponse | en_US |
dc.subject | Tertiary response | en_US |
dc.subject | Therapeutic drug monitoring | en_US |
dc.subject | Ulcerative colitis | en_US |
dc.title | Dose intensification strategy influences infliximab pharmacokinetics but not clinical response after the same number of doses. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Journal of Gastroenterology and Hepatology | en_US |
dc.identifier.affiliation | Department of Gastroenterology, Eastern Health, Melbourne, Australia. | en_US |
dc.identifier.affiliation | Gastroenterology and Hepatology | en_US |
dc.identifier.affiliation | Department of Immunopathology, NSW Health Pathology Liverpool Hospital, Sydney, Australia. | en_US |
dc.identifier.doi | 10.1111/jgh.16133 | en_US |
dc.type.content | Text | en_US |
dc.identifier.orcid | 0000-0001-5952-1570 | en_US |
dc.identifier.orcid | 0000-0002-3399-7236 | en_US |
dc.identifier.orcid | 0000-0003-3662-6307 | en_US |
dc.identifier.pubmedid | 36692034 | - |
local.name.researcher | De Cruz, Peter P | |
item.grantfulltext | none | - |
item.openairetype | Journal Article | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Gastroenterology and Hepatology | - |
crisitem.author.dept | Gastroenterology and Hepatology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.